Page 76 - Craniomaxillofacial Implant Surgery - Jeroen P.J. Dings

74
Chapter 4
REFERENCES
1. Visser A, Raghoebar GM, van Oort RP, Vissink A. Fate of implant-retained craniofacial prostheses: life span and aftercare. Int J Oral Maxillofac Implants 2008; 23 :89–98
2. Leonardi A, Buonaccorsi S, Pellacchia V, Moricca LM, Indrizzi E, Fini G. Maxillofacial prosthetic rehabilitation using extraoral implants. J Craniofac Surg 2008; 19: 398–405
3. Clauser L, Sarti E, Dallera V, Galiè M. Integrated reconstructive strategies for treating the anophthalmic orbit. J Craniomaxillofac Surg 2004; 32: 279–90
4. Schoen PJ, Raghoebar GM, van Oort RP, et al. Treatment outcome of boneanchored craniofacial prostheses after tumor surgery. Cancer 2001; 92: 3045–50
5. Arcuri MR, LaVelle WE, Fyler A, Funk G. Effects of implant anchorage on midface prostheses. J Prosthet Dent 1997; 78: 496–500
6. Oh WS, Roumanas E, Beumer J. Maxillofacial restoration after head and neck tumor therapy. Compend Contin Educ Dent 2007; 28: 70–6
7. Futran ND, Mendez E. Developments in reconstruction of midface and maxilla. Lancet Oncol 2006; 7: 249–58
8. Granstrom G. Craniofacial osseointegration. Oral Dis 2007; 13: 261–9
9. Schlegel KA, Schultze-Mosgau S, Eitner S, Wiltfang J, Rupprecht S. Clinical trial of modified ankylos implants for extraoral use in cranio- and maxillofacial surgery. Int J Oral Maxillofac Implants 2004; 19: 716–20
10. Wolfaardt JF, Wilkes GH. Craniofacial osseointegration. J Can Dent Assoc 1994; 60: 805–9
11. Nishimura RD, Roumanas E, Moy PK, Sugai T, Freymiller EG. Osseointegrated implants and orbital defects:
U.C.L.A. experience. J Prosthet Dent 1998; 79: 304–9
12. Parel SM, Tjellström A. The United States and Swedish experience with osseointegration and facial
prostheses. Int J Oral Maxillofac Implants 1991; 6: 75–9
13. Miles BA, Sinn DP, Gion GG. Experience with cranial implant-based prosthetic reconstruction. J Craniofac Surg
2006; 17: 889–97
14. Tolman DE, Desjardins RP, Jackson IT, Brånemark PI. Complex craniofacial reconstruction using an implant-
supported prosthesis: case report with longterm follow-up. Int J Oral Maxillofac Implants 1997; 12: 243–51
15. Granström G. Radiotherapy, osseointegration and hyperbaric oxygen therapy. Periodontol 2000 2003; 33:
145–62
16. Kosmidou L, Toljanic JA, Moran WJ, Panje WR. The use of percutaneous implants for the prosthetic rehabilitation of orbital defects in irradiated cancer patients: a report of clinical outcomes and complications. Int J Oral Maxillofac Implants 1998; 13: 121–6
17. Granström G, Tjellström A. Effects of irradiation on osseointegration before and after implant placement: a report of three cases. Int J Oral Maxillofac Implants 1997; 12: 547–51
18. Roumanas ED, Freymiller EG, Chang TL, Aghaloo T, Beumer 3rd J. Implantretained prostheses for facial defects: an up to 14-year follow-up report on the survival rates of implants at UCLA. Int J Prosthodont 2002; 15: 325–32
19. Chang TL, Garrett N, Roumanas E, Beumer J. Treatment satisfaction with facial prostheses. J Prosthet Dent 2005; 94: 275–80
20. Hooper SM, Westcott T, Evans PL, Bocca AP, Jagger DC. Implant-supported facial prostheses provided by a maxillofacial unit in a U.K. regional hospital: longevity and patient opinions. J Prosthodont 2005; 14: 32–8
21. Raghoebar GM, van Oort RP, Dikkers FG, Reintsema H. Fixation of facial and auricular prosthesis with osseous implants in cranial bone. Ned Tijdschr Geneeskd 1998; 142: 525–8
22. Cune MS, Bogie LB, van Es RJ, Verhoeven JW, Steijvers MP, Rutges PJ. Dental feats 1. An implant-supported orbital prosthesis after ablative tumor surgery. Ned Tijdschr Tandheelkd 2003; 110: 271–5
23. Abu-Serriah MM, McGowan DA, Moos KF, Bagg J. Outcome of extra-oral craniofacial endosseous implants. Br J Oral Maxillofac Surg 2001; 39: 269–75
24. Scherer UJ, Schwenzer N. A new implant site in iliac crest bone graft for retention of orbital epistheses: a preliminary report. Br J Oral Maxillofac Surg 1995; 33: 289–94
25. Mouriaux F, Martinot V, Pellerin P, Patenotre P, Rouland J, Constantinides G. Survival after malignant tumors of the orbit and periorbit treated by exenteration. Acta Ophthalmol Scand 1999; 77: 326–30